SMA lines? Golden Crosses? What is this 1974?.. Everyone

New Post Public Reply Private Reply Replies (0) Message Board
joey68
SMA lines? Golden Crosses? What is this 1974?..

Everyone always talks about 'SMA golden crosses' and 'Whoa! watch out! 200sma about to cross!'

In my reality, these lines mean diddly squat. Here are the most important lines youll ever need to know:

fast EMA line: 13
slow EMA line: 48.5

Go to stockcharts.com, plug in OCWP, uncheck the 'log' box and enter these numbers for EXPONENTIAL MOVING AVERAGE.

Actually.. heres the link of the chart already filled in:

..prepare to become 500 steps ahead of everyone else...


OWCP using EMA lines

You see, many investors blindly use SMA lines, touting GOLDEN CROSS! BAHHHH!.. but they have no idea why they use 50 and 200 SMA lines in the first place.

This is why I use EMAs:

Quote:
Exponential moving averages (EMAs), which weigh most recent prices heavier than earlier prices , perform better overall than SMAs, which weight all prices in the timeframe equally.


So go back to the chart in the above link, and be amazed at the EMA crossover OWCP had back on October 5th.

and if youre still asking yourself why the EMA lines are better than SMA lines.. check this out:

Your SMA lines are a slow turd compared to my EMA's!

Look at the above chart. Its using standard 50 and 200 SMA lines. Notice anything?? THEY HAVE NOT EVEN CROSSED YET! This is how I knew to get into OWCP early. The EMA lines crossed WAAAAY before the SMA lines. And why...?

Quote:
Exponential moving averages (EMAs), which weigh most recent prices heavier than earlier prices, perform better overall than SMAs, which weight all prices in the timeframe equally.


Hey, don't take my word for it. Feel free to use the 50 and 200 SMA lines all you want. But when everyone else is touting 'GOLDEN CROSS SOON!'.. my EMA lines will already have indicated to me whether or not a golden cross formed.

Note:
If you think I made up these data points of 13 and 48.5, think again. Do research and see for yourself.

Not investment advice. Go talk to a professional investment advisor.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baystate Health Expands: A New Chapter with Mercy

Updated Category News Views 138

Baystate Health Moves Forward with Strategic Integration Well, here's a tale that's as much about legacy as it is about progress. Baystate Health has brought Baystate Mercy Hospital into its fold, blending history with future prospects. This integration, folks, isn't just a merger—it's a downright overhaul of how healthcare operates in Western Massachusetts. We’re...

Continue Reading
Knob-and-Tube Wiring: A Hidden Hazard Unveiled

Updated Category News Views 185

Unlocking the Mysteries of Knob-and-Tube Wiring Ever wondered if the wiring in your charming hundred-year-old home might be a ticking time bomb? Welcome to the world of knob-and-tube wiring. This blast from the past might just be hiding in those walls and could spell trouble. The History and Hazards of Knob-and-Tube This wiring system dates back to the 1880s, sticking...

Continue Reading
Shenzhen's Theme Song Unveils APEC 2026 Vision

Updated Category News Views 273

A Harmonious Prelude to APEC China 2026 Ever experienced an anthem that captures a city's pulse? That's what Shenzhen's latest creation aims for as it gears up for APEC China 2026. The Publicity Department of the CPC Shenzhen Municipal Committee, alongside Shenzhen Media Group, has crafted something more than just a tune. This is 'Meet You Where Wonders Bloom', a melody...

Continue Reading
Gildan Faces Class Action Deadline Over Fraud Claims

Updated Category News Views 95

Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...

Continue Reading
TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Updated Category News Views 287

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Continue Reading
Abbott's SonicForce Impresses in Crucial Clinical Trial

Updated Category News Views 147

Breaking Through Cardiac Barriers Never thought I'd see the day when we're literally sending shockwaves through the heart, but here we are. Abbott's makin' waves, quite literally, with its SonicForce™ Coronary Intravascular Lithotripsy (IVL) System. They’ve just dropped some promising 30-day outcomes from the TECTONIC study, which has grabbed the spotlight at the...

Continue Reading
Wujiang Celebrates 90 Years of Fei Xiaotong's Legacy

Updated Category News Views 0

If you thought anniversaries were just about looking back, think again! In Wujiang, November 1st was all about forging ahead. Scholars and local officials weren't just reminiscing about Fei Xiaotong's landmark field study at Jiangcun 90 years ago; they were strategizing how to apply the sociologist's insights to today's economic and community challenges. Marking a Legacy...

Continue Reading
Nanchang Expo Showcases Future of Aviation and Space

Updated Category News Views 112

Aviation Dreams Take Off in Nanchang Not every day you see an expo spanning 30,000 square meters focused on aviation, especially where East meets innovation—Nanchang, the beating heart of Jiangxi Province, China, is where it's all happening this time around. October 31, 2026, saw the city launching not rockets but the 2026 Nanchang Aviation Industry Expo, and folks,...

Continue Reading
Roof Flashing Insights with Expert Jeremiah Lightsey

Updated Category News Views 300

Why Flashing Is the Backbone of a Leak-Free Roof Ever wonder why some roofs just seem to withstand the wrath of Mother Nature better? The answer, my friends, often boils down to a little unsung hero: roof flashing. Our roof parts aren't exactly playing an even game; you've got chimneys, walls, skylights, just asking for trouble. That's where flashing steps in like an...

Continue Reading
HashKey and RD Tech Partner for RDUSD Expansion

Updated Category News Views 0

A Partnership with Serious Implications Here's a fresh duo in the financial frontier—HashKey On-Chain and RD Technologies are teaming up in a bid to push the RDUSD stablecoin into the heart of cross-border trade and finance. And why does it matter? Well, in the wild west of digital finance, stablecoins are the solid ground, and these two are planting their flag. It's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Diabetes-Related Eye Treatment Market Expected to Surge

Updated Category News Views 71

Overview of Diabetes-Associated Ophthalmic Treatments The global market for diabetes-related eye treatments is experiencing significant growth, with projections indicating an increase from USD 29.75 billion in 2023 to an impressive USD 56.43 billion by 2033. This growth reflects a remarkable compound annual growth rate (CAGR) of 6.61% over the next ten years. The...

Continue Reading
EverBank's Acquisition Strategy Enhances Life Premium Financing

Updated Category News Views 224

EverBank's Strategic Acquisition of Life Premium Finance Division EverBank, N.A. has recently made an exciting announcement regarding its strategic growth initiatives. The bank has entered into an agreement to acquire the Life Premium Finance division from Primis Bank, a step that promises to enhance its offerings to both consumer and commercial clients across the nation....

Continue Reading
Banyan Tree Mount Emei: A Sanctuary Redefined

Updated Category News Views 32

What Banyan Tree's Expansion Means for Investors Investing in the hospitality sector might not seem like rocket science, but moves like Banyan Tree's latest expansion into China can certainly stir the pot. Nestled at Mount Emei in Sichuan Province, they've laid down a new marker in a region teeming with cultural significance and natural beauty. A Scenic Destination with...

Continue Reading
DUPIXENT: A Game Changer in Chronic Obstructive Pulmonary Disease

Updated Category News Views 280

Transforming the COPD Treatment Landscape with DUPIXENT After years of stagnant progress in the treatment of chronic obstructive pulmonary disease (COPD), the healthcare landscape has seen a revolutionary change. Patients struggling with this lung condition now have new treatment options thanks to the innovative efforts of Regeneron and Sanofi. Their flagship product,...

Continue Reading
Ensign Group Stock Soars: A Detailed Look at Growth Prospects

Updated Category News Views 116

Ensign Group's Impressive Growth and Strategic Expansion Recently, Stephens has raised the price target for The Ensign Group Inc. (NASDAQ: ENSG) from $163 to an impressive $167, while maintaining an Overweight rating on the stock. This reflects the company's significant achievement in occupancy rates, reaching a record of 81.7% in their same-store portfolio during the...

Continue Reading